LBP and Parkinson disease: Clinical neuroimaging evidence further supports this mechanism: serum LPS-binding protein (LBP) levels in PD patients are significantly correlated with the extent of microglial activation in the substantia nigra (quantified by ^11C-PK11195 PET) (37) (Figure 1).